Improving CAR T-Cell Therapies With Greater Understanding of Cancer Immunology
October 8th 2019Eduardo Sotomayor, MD, discusses the evolution of CAR T-cell therapy, adverse events that require careful monitoring, and novel strategies under development that may mitigate toxicity and improve T-cell persistence.